| Period Ending | Mar 31, 2010 | Mar 31, 2009 | Mar 31, 2008 | Mar 31, 2007 |
|---|
|
Total Revenue
|
95,438,000
|
127,726,000
|
60,232,000
|
58,036,000
| | Cost of Revenue | 51,796,000 | 81,090,000 | 36,504,000 | 35,796,000 | | |
Gross Profit
|
43,642,000
|
46,636,000
|
23,727,000
|
22,240,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 81,352,000 | 112,484,000 | 52,802,000 | 50,755,000 | | | |
Operating Income or Loss
|
14,086,000
|
15,242,000
|
7,430,000
|
7,281,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 14,086,000 | 15,242,000 | 7,430,000 | 7,281,000 |
|
Interest Expense | (3,932,000) | (3,953,000) | (1,365,000) | (962,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 2,093,000 | 1,575,000 | 2,115,000 | 2,401,000 |
|
Minority Interest | (1,311,000) | (1,117,000) |
-
|
-
|
|
|
|
Net Income From Continuing Ops | 6,059,000 | 6,481,000 | 9,644,000 | 5,080,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
6,059,000
|
6,481,000
|
9,644,000
|
5,080,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|
0.30%